FDA Grants Belgian Crohn’s Disease Candidate Orphan Designation
TiGenix has seen its Crohn’s disease candidate receive orphan drug designation after agreeing on a global Phase III trial. TiGenix exploits the anti-inflammatory properties of donor-derived stem cells to treat diseases. One of its candidates, Cx601, is targeted at Crohn’s disease – …
This awesome article FDA Grants Belgian Crohn’s Disease Candidate Orphan Designation appeared first on Labiotech.eu. Be kind and don’t copy it without asking 😉
Meet the Founder & CEO of this European Biotech Role Model
Onno van de Stolpe founded Galapagos nearly 20 years ago and still is CEO of this European biotech success story. I caught up with him for the full story. It was when he was studying at the agricultural university in …
This awesome article Meet the Founder & CEO of this European Biotech Role Model appeared first on Labiotech.eu. Be kind and don’t copy it without asking 😉